Results 201 to 210 of about 711,939 (323)

CircLRBA Promotes Epithelial‐Mesenchymal Transition, Immune Evasion, Chemoimmunotherapy Resistance and Metastasis Through Stabilizing Twist1

Advanced Science, EarlyView.
CircLRBA is highly expressed in breast cancer (BC) and associated with poor overall survival. Zeb1 mediated circLRBA facilitates BC cell proliferation, invasion, docetaxel (DTX) resistance and inhibits the infiltration of CD8+ T cell. CircLRBA could combine with SPOP to suppress the Twist1 ubiquitination degradation and enhances PD‐L1 transcription ...
Xiaosong Wang, Xin Yang, Lei Xing, Hang Chen, Fuming Xie, Bin Wang, Bowen Shi, Yan Yang, Junxia Chen   +8 more
wiley   +1 more source

Avidity‐Based Capture of PD‐L1‐Expressing Exosomes via Dendrimer–Peptide Conjugates: A Nanoengineered Platform for Enhanced Prediction of Immunotherapy Response

Advanced Science, EarlyView.
This study introduces a dendrimer‐peptide conjugate platform (G7‐pPDL1) for avidity‐based capture of PD‐L1‐expressing exosomes. The system exhibits enhanced binding kinetics and exosome capture efficiency, enabling accurate prediction of immunotherapy outcomes.
Jiah Lee, Dongjun Shin, Chae Yeon Son, Hanbit Kang, Jung Hyun Choi, Hyun Sung Park, Seha Bang, Lucia Kim, Tae Hee Lee, Hyuk Soo Eun, Michael J Poellmann, Woo‐jin Jeong, Dong Hyung Kim, Jun Hyeok Lim, Seungpyo Hong, Jiyoon Bu   +15 more
wiley   +1 more source

The Size-Growth Rate Relationship in Hepatocellular Carcinoma. [PDF]

JGH Open
Gnanendran D, Olaru A, Shah M, Jackson J, Venkatachalapathy SV, Aravinthan AD.   +5 more
europepmc   +1 more source

Clinical course on patients with primary hepatocellular carcinoma surviving longer than one year.

, 1977
Mikio Nishioka, Hideo Nishimura, Toshinori Harada, Kojiro Shigeta, Kiwamu Okita, Takahiro Kodama, Mikio Hayakawa, Toshihiko Takenami, Tomiko OKA, Etsuo Akagawa, J Nawata, Kenichi Noda, Yohei Fukumoto, Taizo Kan, Ryoko FUJII, Minoru Mizuta, Tadayoshi Takemoto   +16 more
openalex   +2 more sources

Advanced Image‐Guidance and Surgical‐Navigation Techniques for Real‐Time Visualized Surgery

Advanced Science, EarlyView.
This review comprehensively summarizes advances in surgical navigation, covering both established and emerging intraoperative imaging technologies. It highlights mechanisms, advantages, limitations, and clinical applications, while emphasizing interdisciplinary collaboration.
Xiaoxiao Fan, Xiaolong Liu, Qiming Xia, Guoqiao Chen, Jiaxi Cheng, Zhaoqi Shi, Yifeng Fang, Parikshit Asutosh Khadaroo, Jun Qian, Hui Lin   +9 more
wiley   +1 more source

Are we overestimating success of salvage hepatectomy in unresectable hepatocellular carcinoma? [PDF]

World J Clin Oncol
Meena BL, Sharma D.
europepmc   +1 more source

Cellular immunity in hepatocellular carcinoma

, 1978
Daizo KAN
openalex   +2 more sources

Hepatocellular carcinoma and exposure to hexachlorobenzene: a case report. [PDF]

, 1989
Clare Selden, Gunilla B. Jacobson, Petronella J. Van den Berg, Olav Axelson   +3 more
openalex   +1 more source

Hyaluronic Acid Hydrogel Implants for Sustained Release of Oxaliplatin and Resiquimod to Prevent Hepatocellular Carcinoma Recurrence Post‐Radiofrequency Ablation

Advanced Science, EarlyView.
Preparation of a biopolymer‐based immune implant (BI) for the sustained release of R848 and oxaliplatin (OXA), enabling immune activation and preventing recurrence after radiofrequency ablation (RFA) treatment in hepatocellular carcinoma (HCC). Abstract Hepatocellular carcinoma (HCC) remains a global challenge due to limited therapies and high ...
Yuezhan Shan, Hongyu Chu, Sheyu Ye, Guofeng Ji, Jiayi Zhao, Xinghui Si, Yumin Zhong, Youmao Tao, Jingwei Shi, Xuedong Fang   +9 more
wiley   +1 more source

RADIOFREQUENCY ABLATION OF THE PREVALENCE IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA: A PERSPECTIVE OF HUMAN SCIENCES

, 1970
Mário Fabrício Fleury Rosa, Suélia de Siqueira Rodrigues   +1 more
openalex   +2 more sources